Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-10-29
1989-08-08
Sutto, Anton H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544231, 548485, 560 30, A61K 31505, C07D48710
Patent
active
048552984
ABSTRACT:
A quinazolinone derivative of the formula: ##STR1## wherein R.sup.1 is hydrogen atom or a halogen atom, or a salt thereof and processes for preparing the same are disclosed. The quinazolinone derivative (I) is useful for treatment of diabetic complications.
REFERENCES:
patent: 4248882 (1981-02-01), Sarges
patent: 4273775 (1981-06-01), Sarges
patent: 4282229 (1981-08-01), Sarsas
patent: 4533667 (1985-08-01), Hutchison
patent: 4575507 (1986-03-01), Lipinski
patent: 4762839 (1988-08-01), Yamada et al.
Capuano et al., I, Chem. Ber., 103, p. 2394 (1970).
Capuano et al., II, Chem. Ber., 110, p. 3849 (1977).
Matsuoka Yuzo
Yamada Yoshihisa
Bernhardt Emily
Sutto Anton H.
Tanabe Seiyaku Co. Ltd.
LandOfFree
6-Halo-1,2,3,4-tetrahydr oquinazoline-4-spiro-4-imidazolidine-2, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-Halo-1,2,3,4-tetrahydr oquinazoline-4-spiro-4-imidazolidine-2,, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-Halo-1,2,3,4-tetrahydr oquinazoline-4-spiro-4-imidazolidine-2, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905762